Menopause and Botulinum Toxin

Elaine Williams, Ana Silva

Research output: Contribution to Specialist PublicationArticle

Abstract

The menopause transition is a natural phase of women’s lives.

Generally between the ages of 42 to 55, many women experience perimenopausal symptoms, which are described as a group of symptoms related to autonomic nervous dysfunction in women. These symptoms are a consequence of pituitary hyper-function and ovarian function decline, with consequent fluctuation and/or decline in oestrogen levels. There are understood to be 34 known symptoms related to PMS, which include hot flushes, night sweats, depression and anxiety. Literature presents evidence of women’s lived experience of shame relating to menopause symptoms, and pervasive, negative discourses regarding menopause and ageing. Loss of oestrogen activity may negatively impact mental wellbeing, including the experience of ageing.
Original languageEnglish
Pages31-33
Number of pages3
Volume9
No.9
Specialist publicationAesthetics Journal
Publication statusPublished - 1 Aug 2022

Keywords

  • Menopause
  • Depression
  • Botulinum Toxin
  • Neurotoxin

Fingerprint

Dive into the research topics of 'Menopause and Botulinum Toxin'. Together they form a unique fingerprint.

Cite this